Editor in Chief Dr KK Aggarwal, Padma Shri Awardee                                                                               Dated:18 July,2020

New studies clarify what drugs help, hurt for COVID-19

Fresh studies give more information about what treatments do or don't work for COVID-19, with high-quality methods that give reliable results. ,British researchers on Friday published their research on the only drug shown to improve survival -- a chesteroid called dexamethasone. Two other studies found that the malaria drug hydroxychloroquine does not help people with only mild symptoms.
For months before studies like these, learning what helps or harms has been undermined by "desperation science" as doctors and patients tried therapies on their own or through a host of studies not strong enough to give clear answers. ,"For the field to move forward and for patients' outcomes to improve, there will need to be fewer small or inconclusive studies" and more like the British one, Drs. Anthony Fauci and H. Clifford Lane of the National Institutes of Health wrote in the New England Journal of Medicine. ....read more


CMAAO Coronavirus Facts and Myth Buster: Around the globe

With inputs from Dr Monica Vasudev
986: COVID-19 patients have been found to have 27 times higher likelihood than others to have lost their sense of smell. However, they had merely 2.6-fold higher odds of having fever or chills. So then, why are we measuring the temperature as a detection method for asymptomatic COVID-19? Why not measure the smell and taste as the screening method.
987: How Does Antigen Test Work: First category of COVID-19 tests includes RT-PCR, TrueNat, CBNAAT and Antigen test. These tests tend to detect the virus in the body. The second category, the serologic test, is meant to detect antibodies that are produced in the body to protect it against the virus. ....read more


World Covid Meter 17th July: India Number 3, 213 Countries Affected

Cases: 1M: April 2, 2M April 15, 3M April 27, 4M May 8, 5M May 20, 6M May 30, 7M June 7, 8M June 15, 9M June 22, 10M June 29, 11M July 4, 12M July 8, 13M July 13 ,Ground Zero: Wuhan - in live animal market or cafeteria for animal pathogens: 10th January; Total cases are based on RT PCR, 67% sensitivity ,Doubling time India 20 days, USA 33 days, Brazil 13 days, Russia 18 days, Spain 47 days, UK 35 days, Italy 55 days, France 49 days, Turkey 37 days ,Coronavirus Cases: 13,946,170,Deaths: 592,673,Recovered: 8,277,510,ACTIVE CASES: 5,075,987 ....read more


Do Your Duty with Discipline and Devotion

“Vasudhaiva kutumbakam” (the whole world is one family) and “Ekam Sat Viprah Bahudavanti” (truth is one but the wise call it by various names) are two basic statements, which come from the ancient Rig Veda and form the fundamentals of Vedic philosophy. ,One should do one’s duty with devotion and discipline. This principle can be remembered as the principle of three Ds.
In daily routine ‘one should remember the purpose for which one is born, which is to fulfill Dharma (duty), Artha (wealth), Kama (desire) and Moksha (liberation). To achieve them, one needs to follow the four Fs: (i) Follow the teacher (ii) Face the negative devils of the mind (iii) Fight till the end and (iv) Finish at the goal. ....read more


Video of The day

Cross ventilation the best clinic in COVID 19 era


Medbytes

       


Healthcare News Monitor
Caught profiteering off Covid lifesaving drugs
India Today

Sharks in the pharma supply chains are stockpiling and black-marketing a key life-saving drug for Covid-19, an India Today investigation has found. ,Remdesivir, produced by America's Gilead Sciences, is touted as the best hope for critically-ill coronavirus patients for its ability to shorten recovery times in clinical trials. ,Gilead has licensed several drugmakers in India to make its generic versions.
"Anybody involved in black marketing will be punished strictly," Delhi’s Deputy Chief Minister Manish Sisodia said in response to India Today's undercover investigation into the black-marketing of life-saving Covid-19 drug Remdesivir.

A network of Indian volunteers is trying to rebuild the supply chain for this life-saving drug
Scroll.in

A senior police officer in Odisha, a disability rights commissioner in Tamil Nadu, customs and airline officials around the country, health ministry bureaucrats, pharmaceutical company executives, public health activists, and parents of children with epileptic seizures. This is the main cast of people who have been working tirelessly since the Covid-19 pandemic hit India in March to procure an important drug – vigabatrin – that helps prevent epileptic seizures in children.
While vigabatrin, which comes as a strip of 10 tablets, has always been bought and sold in India’s grey market, the Covid-19 pandemic and the lockdown broke down a system that was already precarious, an IndiaSpend investigation has found. It was easier and cheaper to source vigabatrin from the grey market before the pandemic than it is right now, families told IndiaSpend.

Patients prefer to meet their doctors in person than consult online: Study
E-Health

A recent study by the research team at Madras Diabetes Research Foundation and Dr. Mohan’s Diabetes Specialities Centre found that patients preferred to meet their doctors in person than consult them over telephone. The research was conducted to assess the effects of the lockdown on the adoption of new technologies and changes in diabetes in type 2 diabetes patients. Researchers spoke to patients from
Dr. Mohan’s Diabetes Specialities Centre (DMDSC) one of India’s largest tertiary care centers for diabetes, with a network of 48 diabetes centers across different regions. The study also found that despite the lockdown, the control of diabetes amongst patients actually increased during the past months.

Pune: Retd scientist dies as family fails to find ICU bed for him in private hospitals
The Indian Express

A 61-year-old man died early Wednesday morning after his family’s desperate search to find an ICU bed for him in the city’s private hospitals, as well as the government-run Sassoon Hospital, proved futile.
The family of Dr Lakshmi Narsimhan, a scientist who retired from the Botanical Survey of India last year, first went to a private hospital located on Nagar Road where they were reportedly told that no ICU bed was available.
“On Tuesday evening, my brother-in-law had breathing problems. His wife and daughter then rushed him to a private hospital, where the doctors said there was no ICU bed available. They then contacted me, and I got in touch with Congress leaders and friends Ramesh Iyer and Arvind Shinde. All of us tried to contact different private hospitals, but none of them had ICU beds available. We then decided to take him to Sassoon Hospital,” said S Madhavan, a close relative.